Altamira Therapeutics Ltd. (EARS) Earning

NASDAQ Currency in USD Disclaimer

$3.05

north_east NA Past Year
Day's range
$3
Day's range
$3.09

Altamira Therapeutics Ltd. Earnings History by Quarter

Date Quarter Consensus Estimate Reported EPS Beat/Miss Revenue Estimate Actual Revenue
06/28/2023 Q2 2023 -$12.91 $52,735
03/30/2023 Q1 2023 -$12.97 $52,735
05/16/2023 Q4 2022 -$2.89 $0
09/29/2022 Q3 2022 -$199.86 $-458,691
11/30/2022 Q2 2022 -$106.32 $145,399
11/30/2022 Q1 2022 -$106.32 $145,399
04/12/2022 Q4 2021 $164.89 $0
09/29/2021 Q3 2021 -$149.92 $0
03/31/2021 Q2 2021 -$108.47 $0
03/31/2021 Q1 2021 -$108.47 $0
03/31/2021 Q4 2020 -$148.91 $237,000
09/29/2020 Q3 2020 -$148.91 $0
09/17/2020 Q2 2020 -$115.96 $0
09/17/2020 Q1 2020 -$115.96 $0
04/16/2020 Q4 2019 -$83.44 $-56,000
09/29/2019 Q3 2019 $0.00 $0
06/30/2019 Q2 2019 -$165.85 $0
03/30/2019 Q1 2019 $0.00 $0
03/14/2019 Q4 2018 -$485.21 $1.27 M
09/30/2018 Q3 2018 -$569.22 $0
 

Altamira Therapeutics Ltd. Earnings: FAQ's

How can I listen to Altamira Therapeutics Ltd.'s earnings conference call?

The conference call for Altamira Therapeutics Ltd.'s latest earnings report can be listened to online.

How can I read Altamira Therapeutics Ltd.'s conference call transcript?

The conference call transcript for Altamira Therapeutics Ltd.'s latest earnings report can be read online.

How much profit does Altamira Therapeutics Ltd. generate each year?

Altamira Therapeutics Ltd. (:EARS) has a recorded net income of $0. Altamira Therapeutics Ltd. has generated $-14.81 earnings per share over the last four quarters.

What is Altamira Therapeutics Ltd.'s price-to-earnings ratio?

Altamira Therapeutics Ltd. (:EARS) has a price-to-earnings ratio of -0.02 and price/earnings-to-growth ratio is -0.

Portfolio Sync
Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED